Gel-One® Cross-linked Hyaluronate
- Primary DI
- 00087541300912
- Brand
- Gel-One® Cross-linked Hyaluronate
- Company
- SEIKAGAKU CORPORATION
- Model
- 00-1111-001-00
- Catalog number
- 00-1111-001-00
- Device description
- Gel-One is a cross-linked hyaluronate hydrogel that is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics (e.g., acetaminophen). Gel-One is physician-administered, and is injected directly into the cavity of the knee joint. It is delivered via a single-use, pre-filled disposable glass syringe containing 3 mL of Gel-One.
- Published
- 2014-09-17
- Public version status
- Update
- Distribution status
- Not in Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
- Sterile
- true
- Single use
- true
Contact Domains#
Product Codes#
| Code | Name |
|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular | Unknown | 3 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| P080020 | 012 |
| P080020 | 013 |
| P080020 | 014 |
| P080020 | 015 |
| P080020 | 016 |
| P080020 | 017 |
| P080020 | 018 |
| P080020 | 019 |
| P080020 | 020 |
| P080020 | 021 |
| P080020 | 022 |
| P080020 | 023 |
| P080020 | 024 |
| P080020 | 025 |
| P080020 | 027 |
| P080020 | 028 |
| P080020 | 029 |
| P080020 | 030 |
| P080020 | 031 |
| P080020 | 032 |
| P080020 | 033 |
| P080020 | 035 |
| P080020 | 036 |
| P080020 | 037 |
| P080020 | 038 |
| P080020 | 039 |
| P080020 | 040 |
Premarket Details#
| Submission | Supplement | Device | Applicant | Decision date | Product code |
|---|---|---|---|---|---|
| P080020 | 012 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 013 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 014 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 015 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 016 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 017 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 018 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 019 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 020 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 021 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 022 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 023 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 024 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 025 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 027 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 028 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 029 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 030 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 031 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 032 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 033 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 035 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 036 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 037 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 038 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 039 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
| P080020 | 040 | GEL-ONE | Seikagaku Corp. | 2011-03-22 | MOZ |
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 00087541300912 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | UPC-A | EAN-13 |
|---|---|---|---|
| 00087541300912 | 00087541300912 | 087541300912 | 0087541300912 |
GMDN Terms#
| Term | Definition |
|---|---|
| Synovial fluid supplementation medium | A sterile viscous/elastic solution or gel (e.g., comprised of hyaluronic acids and their polymeric derivatives) intended to be injected into joints (particularly large, load-bearing joints such as the hip or knee) to help cushion the joint, especially in cases of endogenous synovial fluid reduced viscosity from degenerative disease. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Storage Environment Temperature | 0 Degrees Celsius | 25 Degrees Celsius |
Sterilization Methods#
| Method |
|---|
Contacts#
| Phone | |
|---|---|
| 8003482759 | xxx@xxx.xxx |
| 5743724999 | xxx@xxx.xxx |
Regulatory Flags#
- DUNS number
- 690584057
- Device count
- 1
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| M717715644440 | SUPARTZ FX sodium hyaluronate | 89130-4444-1 | 7156-4444 | 2017-01-31 |
| 04987541301314 | VISCO-3 sodium hyaluronate | 00-1111-001-03 | 00-1111-001-03 | 2017-03-22 |
| 04987541300911 | Gel-One® Cross-linked Hyaluronate | 00-1111-001-00 | 00-1111-001-00 | 2020-01-15 |
| M717715655550 | SUPARTZ® sodium hyaluronate | 89130-5555-01 | 7156-5555 | 2017-01-31 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 05065026658012 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658050 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658005 | Durolane | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658067 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658029 | Monovisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658036 | Orthovisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658043 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658074 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 08052570475131 | Supartz | DAMBO SRL | MOZ | 2025-11-26 |
| M713891220750010 | HYMOVIS® ONE 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | MOZ | 2025-11-07 |
| M713FID075010 | HYMOVIS® ONE Professional Sample, 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | MOZ | 2025-11-07 |
| 08052570473441 | Euflexxa | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570473212 | Durolane | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570473229 | Monovisc | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570477654 | Euflexxa | DAMBO SRL | MOZ | 2025-09-25 |
| 03770034301165 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 03770034301158 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 03770034301172 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 08437027710001 | DUROLANE | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710018 | MONOVISC | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710025 | ORTHOVISC | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710049 | SYNVISC ONE | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710056 | SYNVISC | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| M713891220879010 | TRILURON | FIDIA FARMACEUTICI SPA | MOZ | 2024-05-07 |
| 00193493000753 | GenVisc 850 Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 00193493000760 | TriVisc Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 10193493000750 | GenVisc 850 Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 10193493000767 | TriVisc Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| M713891220724200 | Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL | FIDIA FARMACEUTICI SPA | MOZ | 2023-10-16 |
| 10389130444418 | SUPARTZ FX sodium hyaluronate | BIOVENTUS LLC | MOZ | 2023-09-28 |